Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10%— 510(k) K210126

Substantially Equivalent

The Ritedose Corporation

FDA 510(k) clearance K210126 for Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10%, Substantially Equivalent on 2021-12-03. Applicant: The Ritedose Corporation.

Clearance details

Applicant: The Ritedose Corporation
Product code: Code CAF
Advisory panel: Anesthesiology
Date received: 2021-01-19
Decision date: 2021-12-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Columbia, SC, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code CAF

product code CAF

Death: 22
Injury: 125
Malfunction: 613
Other: 11
Total: 771

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.